Tag Archives: bayer-schering

Global Testosterone Market 2012 – 2016 : Worldwide Industry Latest Market Share,Investment Trends, Growth, Size,Trends …

Albany, NY (PRWEB) October 21, 2013

Global Testosterone Market 2012 – 2016

Global Testosterone market to grow at a CAGR of 26.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population across the globe. The Global Testosterone market has also been witnessing an increasing number of R&D activities that are focused on developing testosterone replacement therapies. However, the entry of generics could pose a challenge to the growth of this market.

To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/global-testosterone-market-2012-2016

Global Testosterone Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas and the EMEA and APAC regions; it also covers the Global Testosterone market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include AbbVie Inc., Auxilium Pharmaceuticals Inc., Actavis Inc., Eli Lilly & Co., and Endo Health Solutions Inc.

The other vendors mentioned in this report are Actient Pharmaceuticals LLC, Acrux Ltd., Bayer Schering Pharma AG, BioSante Pharmaceuticals Inc., GlaxoSmithKline plc, Kyowa Hakko Kirin Co. Ltd., Pfizer Inc., Teva Pharmaceuticals Industries Ltd., and Trimel BioPharma SRL.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/176833

Key questions answered in this report:

TABLE OF CONTENT

More:
Global Testosterone Market 2012 – 2016 : Worldwide Industry Latest Market Share,Investment Trends, Growth, Size,Trends …

Global Testosterone Replacement Therapy (TRT) Industry

NEW YORK, May 21, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:

Global Testosterone Replacement Therapy (TRT) Industry

http://www.reportlinker.com/p0552808/Global-Testosterone-Replacement-Therapy-TRT-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the following Product Segments: Gels, Patches, and Others. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 19 companies including many key and niche players such as Abbott Laboratories, Acrux Limited, Auxilium Pharmaceuticals, Inc., Bayer Schering Pharma AG, Columbia Laboratories, Inc., Eli Lilly and Company, Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Kyowa Hakko Kirin Co., Ltd., ProStrakan Group PLC, Slate Pharmaceuticals, Inc., Trimel BioPharma SRL, and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Read more from the original source:
Global Testosterone Replacement Therapy (TRT) Industry